| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |